HBSXNBM(SH:600293)2022-04-28 16:00Financial Performance - The company's operating revenue for Q1 2022 was CNY 409,396,708.09, representing a decrease of 24.71% compared to the same period last year[5] - The net profit attributable to shareholders was CNY 55,410,518.81, down 8.18% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 49,034,488.25, a decrease of 21.18%[5] - Total operating revenue for Q1 2022 was ¥409,396,708.09, a decrease of 24.7% compared to ¥543,761,592.86 in Q1 2021[17] - Net profit for Q1 2022 was ¥56,901,645.30, a decline of 10.3% from ¥63,454,323.62 in Q1 2021[18] - Operating profit for Q1 2022 was ¥57,869,323.14, compared to ¥65,549,451.14 in Q1 2021, reflecting a decrease of 11.4%[17] - The total comprehensive income for Q1 2022 was ¥56,901,645.30, down from ¥64,720,431.80 in Q1 2021[18] Cash Flow and Assets - The net cash flow from operating activities increased by 150.13% to CNY 40,898,057.40[5] - Cash flow from operating activities for Q1 2022 was ¥40,898,057.40, significantly up from ¥16,350,819.51 in Q1 2021[21] - Cash and cash equivalents increased to RMB 568,603,747.34 from RMB 512,144,689.34, reflecting a rise of approximately 11.01%[14] - Cash and cash equivalents at the end of Q1 2022 totaled ¥424,543,850.65, compared to ¥77,161,104.11 at the end of Q1 2021[22] - The company's current assets totaled RMB 1,389,813,030.36, up from RMB 1,221,071,164.03 at the end of 2021, indicating an increase of about 13.83%[14] - Total assets at the end of the reporting period were CNY 3,952,767,006.01, an increase of 5.08% from the end of the previous year[5] Liabilities and Equity - Total liabilities reached RMB 1,761,601,459.47, compared to RMB 1,627,391,421.86 at the end of 2021, showing an increase of about 8.23%[15] - The equity attributable to shareholders increased by 2.81% to CNY 2,027,796,397.46[5] - The company's equity attributable to shareholders rose to RMB 2,027,796,397.46 from RMB 1,972,385,878.65, reflecting an increase of approximately 2.83%[15] Expenses and Subsidies - Research and development expenses decreased by 74.63% due to lower consumption in ongoing projects[7] - Research and development expenses in Q1 2022 were ¥5,098,708.52, down 74.7% from ¥20,096,854.47 in Q1 2021[17] - Sales expenses for Q1 2022 were ¥2,542,811.37, a decrease of 78.0% compared to ¥11,543,240.54 in Q1 2021[17] - The company received government subsidies that increased other income by 393.41%[7] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 53,925[10]